Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Observational comparison of fospropofol vs propofol for intravenous induction and maintenance of general anesthesia
ChiCTR2400086571Phase 4Not yet recruiting
- Sponsor
- Renmin Hospital of Wuhan University
- Start
- Jul 2024
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of fospropofol disodium in post-operative cognitive decline (POCD) (2 arms), sponsored by Renmin Hospital of Wuhan University. Primary endpoint: Postoperative cognitive dysfunction. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
fospropofol disodium
03
Conditions
post-operative cognitive decline (POCD)
Beyond the preview
Go deeper on ChiCTR2400086571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086571.